or
Bookmark and Share
Treatment methods for lymes disease and associated debilitating conditions
   
Document Number
US Patent 5219882
Issued Date
June 15, 1993
Link
Inventors
Bisaccia; Emil (Basking Ridge, NJ)
Map
Abstract
A method is provided for treating human patients who have Lymes disease by using a psoralen compound, preferably administered in a dosage of 0.3 to 0.7 mg/kg, and activating same either in vitro or in vivo using electromagnetic radiation of a prescribed activating wavelength. The activation of the psoralen compound in the presence of a blood fraction from a patient suffering from Lymes disease produces a composition which will stimulate an effective immune response to the Lymes disease on the part of the patient.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
10
Comments:
no comments yet
Owner
Published
June 15, 1993
Application Number
07/781,962
Filed
October 24, 1991
US Classification
514/455  
Int'l Classification
A61K   31/365   (20060101)   A61K   31/366   (20060101)   A61K   31/37   (20060101)  
Attorney/Law Firm
USPTO Field of Search
514/455  
Related Patents
Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us